These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 1479872)

  • 1. Persistence of Mycobacterium leprae in the peripheral nerve as compared to the skin of multidrug-treated leprosy patients.
    Shetty VP; Suchitra K; Uplekar MW; Antia NH
    Lepr Rev; 1992 Dec; 63(4):329-36. PubMed ID: 1479872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of M. leprae in tissues in slit skin smear negative multibacillary (MB) patients after WHO-MBR.
    Sharma A; Sharma VK; Rajwanshi A; Das A; Kaur I; Kumar B
    Lepr Rev; 1999 Sep; 70(3):281-6. PubMed ID: 10603717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher incidence of viable Mycobacterium leprae within the nerve as compared to skin among multibacillary leprosy patients released from multidrug therapy.
    Shetty VP; Suchitra K; Uplekar MW; Antia NH
    Lepr Rev; 1997 Jun; 68(2):131-8. PubMed ID: 9217352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of corticosteroids usage on bacterial killing, clearance and nerve damage in leprosy; part 3--Study of two comparable groups of 100 multibacillary (MB) patients each, treated with MDT + steroids vs. MDT alone, assessed at 6 months post-release from 12 months MDT.
    Shetty VP; Khambati FA; Ghate SD; Capadia GD; Pai VV; Ganapati R
    Lepr Rev; 2010 Mar; 81(1):41-58. PubMed ID: 20496569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viability of Mycobacterium leprae in skin and peripheral nerves and persistence of nerve destruction in multibacillary patients after 2 years of multidrug therapy.
    Job CK; Jayakumar J; Aschhoff M; Mathan MM
    Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):44-50. PubMed ID: 8627112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In leprosy the presence of mycobacteria in the nerve is an essential factor in the cycle and spectrum of Mycobacterium leprae infection.
    Negesse Y; Beimnet K; Miko T; Wondimus A; Berhan TY
    Lepr Rev; 1993 Jun; 64(2):104-9. PubMed ID: 8341112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comment: Persistence of Mycobacterium leprae in the peripheral nerves of multidrug-treated leprosy patients.
    Grange JM; Beck JS; Abbot NC
    Lepr Rev; 1993 Sep; 64(3):280. PubMed ID: 8110236
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of PCR mediated amplification of DNA and the classical methods for detection of Mycobacterium leprae in different types of clinical samples in leprosy patients and contacts.
    Torres P; Camarena JJ; Gomez JR; Nogueira JM; Gimeno V; Navarro JC; Olmos A
    Lepr Rev; 2003 Mar; 74(1):18-30. PubMed ID: 12669929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are viable Mycobacterium leprae present in lepromatous patients after completion of 12 months' and 24 months' multi-drug therapy?
    Ebenezer GJ; Daniel S; Norman G; Daniel E; Job CK
    Indian J Lepr; 2004; 76(3):199-206. PubMed ID: 15835604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A colorimetric PCR method for the detection of M. leprae in skin biopsies from leprosy patients.
    Jamil S; Wilson SM; Hacket M; Hussain R; Stoker NG
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):512-20. PubMed ID: 7868947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leprosy. An update: definition, pathogenesis, classification, diagnosis, and treatment.
    Eichelmann K; González González SE; Salas-Alanis JC; Ocampo-Candiani J
    Actas Dermosifiliogr; 2013 Sep; 104(7):554-63. PubMed ID: 23870850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of NASBA RNA amplification for detection of Mycobacterium leprae in skin biopsies from untreated and treated leprosy patients.
    van der Vliet GM; Cho SN; Kampirapap K; van Leeuwen J; Schukkink RA; van Gemen B; Das PK; Faber WR; Walsh GP; Klatser PR
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):396-403. PubMed ID: 9030105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viability and drug sensitivity of M. leprae isolated from long-term WHO/MDT treated multibacillary leprosy patients.
    Habtemariam H
    Lepr Rev; 1999 Mar; 70(1):43-6. PubMed ID: 10405543
    [No Abstract]   [Full Text] [Related]  

  • 14. qPCR-High resolution melt analysis for drug susceptibility testing of Mycobacterium leprae directly from clinical specimens of leprosy patients.
    Araujo S; Goulart LR; Truman RW; Goulart IMB; Vissa V; Li W; Matsuoka M; Suffys P; Fontes AB; Rosa PS; Scollard DM; Williams DL
    PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005506. PubMed ID: 28570560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of viable organisms in leprosy patients treated with multidrug therapy.
    Gupta UD; Katoch K; Singh HB; Natrajan M; Sharma VD; Katoch VM
    Acta Leprol; 1999; 11(3):89-92. PubMed ID: 10544720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of 16S rRNA qPCR for detection of Mycobacterium leprae DNA in nasal secretion and skin biopsy samples from multibacillary and paucibacillary leprosy cases.
    Marques LÉC; Frota CC; Quetz JDS; Bindá AH; Mota RMS; Pontes MAA; Gonçalves HS; Kendall C; Kerr LRFS
    Pathog Glob Health; 2018 Mar; 112(2):72-78. PubMed ID: 29279044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Mycobacterium leprae DNA by polymerase chain reaction in the blood of individuals, eight years after completion of anti-leprosy therapy.
    Santos AR; Balassiano V; Oliveira ML; Pereira MA; Santos PB; Degrave WM; Suffys PN
    Mem Inst Oswaldo Cruz; 2001 Nov; 96(8):1129-33. PubMed ID: 11784934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistological localization of mycobacterial antigens within the peripheral nerves of treated leprosy patients and their significance to nerve damage in leprosy.
    Shetty VP; Uplekar MW; Antia NH
    Acta Neuropathol; 1994; 88(4):300-6. PubMed ID: 7839822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study on the impact of FD-MDT on 200 leprosy patients.
    Vara N; Marfatiya Y
    Indian J Lepr; 2005; 77(3):217-27. PubMed ID: 16353520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allocation of patients to paucibacillary or multibacillary drug regimens for the treatment of leprosy--a comparison of methods based mainly on skin smears as opposed to clinical methods--alternative clinical methods for classification of patients.
    Becx-Bleumink M
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):292-303. PubMed ID: 2071986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.